US Stock MarketDetailed Quotes

CLMB Climb Global Solutions

Watchlist
  • 122.590
  • +0.810+0.67%
Close Feb 28 16:00 ET
  • 122.590
  • 0.0000.00%
Post 16:16 ET
564.75MMarket Cap33.22P/E (TTM)

Climb Global Solutions Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Climb Global Solutions Q4 2024 Estimates Date

Currency：USDMar 6, 2025

Estimate YoY
Revenue
114.37M
+7.11%
EPS
1.01
-12.17%
Analyst Rating
Buy

Jan 31, 2025

Climb Global Solutions Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Mar 6, 20252024/Q4-- / 114.373M--
Oct 31, 20242024/Q3119.349M / 122.185M--
Aug 7, 20242024/Q292.076M / 97.266M--
May 2, 20242024/Q192.422M / 105.442M--
Feb 29, 20242023/Q4106.783M / 88.991M--
DatePeriodRevenue/EstimateEarnings Call
Mar 6, 20252024/Q4-- / 114.373M--
Oct 31, 20242024/Q3119.349M / 122.185M--
Aug 7, 20242024/Q292.076M / 97.266M--
May 2, 20242024/Q192.422M / 105.442M--
Feb 29, 20242023/Q4106.783M / 88.991M--

Unlock Free Earnings Estimates

Climb Global Solutions Earnings Reports

  • Climb Global Solutions | 10-Q: Q3 2024 Earnings Report

    Nov 1, 2024 15:02 ET

  • Climb Global Solutions | 8-K: Climb Global Solutions Reports Record Third Quarter 2024 Results

    Oct 30, 2024 16:17 ET

  • Climb Global Solutions | 10-Q: Q2 2024 Earnings Report

    Aug 7, 2024 14:21 ET

  • Climb Global Solutions | 10-Q: Q1 2024 Earnings Report

    May 2, 2024 17:05 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Cars.com
    CARS
    +9.73%
    Lantheus
    LNTH
    +2.55%
    Halozyme Therapeutics
    HALO
    +2.51%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.27%
    Collegium Pharmaceutical
    COLL
    +2.22%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 31, 2025

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data